SPIA
ELTX icon

Steward Partners Investment Advisory’s Elicio Therapeutics ELTX Stock Holding History

Steward Partners Investment Advisory’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.91K Hold
2,023
– – ﹤0.01% 3823
2026
Q1 		$21.6K Buy
2,023
+469
+30% +$4.53K ﹤0.01% 3194
2025
Q4 		$12.4K Hold
1,554
– – ﹤0.01% 3354
2025
Q3 		$17K Hold
1,554
– – ﹤0.01% 3161
2025
Q2 		$12K Hold
1,554
– – ﹤0.01% 3130
2025
Q1 		$9.57K Hold
1,554
– – ﹤0.01% 3118
2024
Q4 		$7.92K Hold
1,554
– – ﹤0.01% 3193
2024
Q3 		$7.82K Hold
1,554
– – ﹤0.01% 3044
2024
Q2 		$6.39K Hold
1,554
– – ﹤0.01% 2971
2024
Q1 		$11.8K Hold
1,554
– – ﹤0.01% 2748
2023
Q4 		$13K Hold
1,554
– – ﹤0.01% 2599
2023
Q3 		$13.1K Hold
1,554
– – ﹤0.01% 2481
2023
Q2 		$14.8K Sell
1,554
-2
-0.1% -$18 ﹤0.01% 2430
2023
Q1 		$9.02K Hold
1,556
– – ﹤0.01% 2577
2022
Q4 		$12.6K Hold
1,556
– – ﹤0.01% 2457
2022
Q3 		$14K Hold
1,556
– – ﹤0.01% 2380
2022
Q2 		$18K Hold
1,556
– – ﹤0.01% 2270
2022
Q1 		$33K Hold
1,556
– – ﹤0.01% 2123
2021
Q4 		$45K Hold
1,556
– – ﹤0.01% 1969
2021
Q3 		$152K Buy
+1,556
New +$168K ﹤0.01% 1382

Other funds holding ELTX

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Steward Partners Investment Advisory's ELTX Position: Q2 2026 in Review

Steward Partners Investment Advisory held its Elicio Therapeutics (ELTX) position steady in Q2 2026 at 2,023 shares worth $7.91K. The position accounts for ﹤0.01% of the portfolio, ranked #3823.

Steward Partners Investment Advisory first reported a position in ELTX in Q3 2021 and has held it in 20 quarters since. The position peaked at $152K in Q3 2021. 48 funds tracked by Wall St. Rank hold ELTX as of Q2 2026.

  • Steward Partners Investment Advisory held 2,023 shares of Elicio Therapeutics worth $7.91K as of Q2 2026.
  • Steward Partners Investment Advisory left its Elicio Therapeutics share count unchanged in Q2 2026.
  • Elicio Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3823 holding.
  • Steward Partners Investment Advisory first reported a position in Elicio Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Steward Partners Investment Advisory's Elicio Therapeutics position peaked at $152K in Q3 2021.
  • 48 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.